IFNG and COVID-19: Subgroup analysis data indicated that both at R2 and R3, SARS-CoV-2-specific immune cell profiles, and their functionality (in terms of CD 107a/IFN-γ expressions) were comparable irrespective of their anti-SARS-CoV-2 antibody status/the clinical presentation of COVID-19 at the time of infection.